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Abstract
Introduction: Primary localized laryngeal amyloidosis is an extremely rare condition. It usually
presents with hoarseness, pain and/or difficulty in breathing.
Case presentation: We present the case of a 23-year-old woman with primary localized laryngeal
amyloidosis who presented with hoarseness and dysphagia.
Conclusion: A search of PubMed shows that dysphagia in patients with laryngeal amyloidosis has
been reported only once, although this symptom is relatively common in other conditions presenting
with laryngeal mass. There were no signs of any systemic disease in our patient and diagnosis was
established histopathologically. She was treated surgically by microlaryngoscopy under general
anesthesia and the mass was excised using a CO2 laser technology method.
Introduction
Amyloidosis is a benign, slowly progressive condition that
is characterized by the presence of extracellular fibrillar
proteins in a variety of organs and tissues. Localized
deposition of amyloid may be observed in individual
organs without any systemic involvement. The progressive
accumulation of amyloid deposits interferes with the
normal structure of affected tissues resulting eventually in
impairment of their function. Localized deposition of
amyloid protein is regarded to be the result of local
synthesis rather than the deposition of light chains
produced elsewhere in the human body.
Primary laryngeal amyloidosis is a rare lesion representing
1% of all benign laryngeal tumors [1]. Dozens of cases of
head andneck organ amyloidosishave been reported in the
literature since Borow [2] described the first case in 1873.
Immunohistochemical stains, and Congo red staining
viewed under polarized light microscopy, or electron
microscopic findings of a laryngeal biopsy specimen can
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degree of suspicion is necessary since clinical presentation
of the disease may mimic that of a laryngeal neoplasm.
Therefore, there is a high risk if the clinician takes the wrong
diagnostic approach. We recommend that an adequate
deep punch biopsy must be obtained in order to exclude
malignancy. Furthermore, an experienced pathologist
should examine the lesion histologically with routine stains
(stain pink with hematoxylin-eosin stain and show
metachromasia with crystal violet) mainly to exclude
malignancy. However, tissue specimens should also be
stainedwithCongoredandexaminedunderpolarized light
microscopy to establish the diagnosis of the disease.
We present a case that underlines the role of birefringence
from red Congo stain to confirm the diagnosis. Another
important feature of our case was that dysphagia was the
main presenting symptom.
Case presentation
A 23-year-old Caucasian Greek woman presented with a
history of progressively worsening hoarseness during the
previous 9 months and recent onset of dysphagia. She
reported no weight loss and she denied the use of tobacco
or excessive alcohol consumption. She had a history of
skin atopy, reporting sensitivity to wool, and a history of
an episode of anaphylactic reaction of unknown cause
2 years previously.
Physical examination of the neck was normal. Indirect
laryngoscopy and endoscopy with a flexible endoscope
revealed a smooth, red-yellow, cystic formation localized
in the left hemilarynx between the false vocal cord and the
aryepiglottic fold. Chest X-ray was normal. A tracheal
computed tomography (CT) scan in 5 mm sections
confirmed the existence of the mass (Figure 1). The
thyroid cartilage appeared intact and no nodal involve-
ment was detected.
We proceeded to perform microlaryngoscopy under
general anaesthesia and removal of the mass (measuring
4 × 2.5 × 2 cm) using a CO2 laser. Pathological examina-
tion revealed a mass with a smooth surface. On macro-
scopic inspection the cut sections were yellow-grey and
solid with a soft and elastic consistency. On microscopy, it
was not clear whether its structure was bundled or
micronodular, consisting of bundles of woven eosinophi-
lic tissue, withsparse fibroblastic cells, several small vessels
and rare atrophic glandular regions. There were also a few
collections of lymphocytes and granulocytes. Staining
with Congo red stain, under polarized light, revealed blue-
green birefringence throughout the mass due to the
presence of amyloid. No signs of malignancy were seen.
Further examinations were done to rule out systemic
amyloidosis. The patient’s complete blood count, erythro-
cyte sedimentation rate, basic metabolic and biochemical
panel and liver function tests were within normal limits.
Serum calcium was also normal. Serum and urine
electrophoresis were normal. Rectal biopsy was negative.
Based on these findings systemic amyloidosis and multi-
ple myeloma were excluded from the differential diag-
nosis. The amyloid light chain was lambda (λ) type. The
amyloid mass was removed by microlaryngoscopy.
Discussion
Amyloidosis is a metabolic protein disturbance in which
extracellular protein fibrils are deposited in various tissues.
Amyloidosis is classified as systemic or local. According to
the type of amyloid, classification of amyloidosis appears
as follows for systemic and localized amyloidoses respec-
tively: hereditary amyloidosis, for example, amyloidosis in
familial Mediterranean fever with types AA, AF amyloid;
idiopathic systemic amyloidosis with AL amyloid; sec-
ondary systemic amyloidoses (reactive amyloidosis) and
chronic infections, neoplastic diseases with AA amyloid
and localized amyloidoses with AL, AA, AK types of
amyloid. Table 1 summarizes the classification of amyloi-
dosis with the accompanying amyloid type. Localized
amyloidosis occurs in a variety of organ systems. Both
Figure 1. Computed tomography scan at the level of the
supraglottis.
Table 1. Classification of amyloidosis.
Type of amyloid
Systemic amyloidoses
I. Hereditary amyloidosis (e.g., amyloidosis in
familiar Mediterranean fever)
AA, AF
II. Idiopathic systemic amyloidosis AL
III. Secondary systemic amyloidoses (reactive
amyloidoses) and chronic infections, neoplastic
diseases
AA
Localized amyloidoses AL, AA, AK
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the past, the extracellular deposition of amyloid in the
larynx was commonly misdiagnosed as vocal cord
nodules. It is now certain that the latter are due to
deposition of fibrin and other factors of local blood
exudation and are unrelated to the rare amyloidosis [1,3].
Primary lesions located in the larynx were first reported in
1873; however, the real pathogenesis of the entity has not
been fully elucidated until now. Apart from a case of
familial primary localized laryngeal amyloidosis in two
sisters and primary localized amyloidosis in various
human organs, familial primary localized amyloidosis of
the larynx has not yet been reported [4]. The familial type
of the disease (ATTP - type amyloid transthyretin protein)
is extraordinarily rare and exhibits an autosomal domi-
nant pattern of inheritance. The extracellular deposits of
amyloid may be focal, limited in one tissue or organ, or
may present systemic distribution. They rarely show
remission but usually tend to increase in size at a slow
but progressive rate. The larynx is rarely the first location of
systemic amyloidosis; however, the latter should not be
ruled out from the differential diagnosis because of its
potentially ominous prognosis.
The ventricles and the false and true vocal cords are the
most common sites for localized amyloidosis in the
respiratory tree [5]. Other sites are the eye, the orbits and
the major and minor salivary glands, while submucosal
deposits have been observed in the nose, paranasal
cavities, nasopharynx, oral cavity, stomatopharynx,
bronchotracheal tree and lungs [6]. Oral and paranasal
amyloidosis is usually a manifestation of systematic
amyloidosis, mainly plasma cell dyscrasia [7]. Laryngeal
amyloidosis usually appears during the fifth and/or sixth
decade of life, without specific symptoms, though it most
frequently involves hoarseness of the voice [1]. Dyspnoea
is a common manifestation of the disease. Interestingly,
apart from hoarseness, our patient was still relatively
young to be complaining of dysphagia. A PubMed search
shows that dysphagia as a clinical symptom has been
reported only once [7]. Additionally, the youngest cases
reported so far in the literature were those of an
11-year-old girl and a 12-year-old girl [8,9].
Regarding the requested laboratory control, in cases of
localized laryngeal amyloidosis, Lewis et al. [10] studied
22 patients in the Mayo Clinic suffering from amyloidosis
located exclusively in the larynx during the period 1950 to
1988 and recommended urine and serum electrophoresis
as a basic initial approach. They did not recommend
bowel and bone marrow biopsies as absolutely necessary.
The most commonly used method to detect the amyloid
protein is the histological staining of biopsy samples
excised with Congo red stain. Amyloid is birefringent in
polarized light and appears apple-green in color (the so-
called dichroism) in Congo red stained sections. This
should be distinguished from pseudoamyloid, which is
often found in vocal cord nodules. This is of fibrous
consistency and represents an amorphous granular degen-
eration of collagen fibers with sparse disseminations
between the fibroblasts [11]. Potassium permanganate
may be used for the discrimination of protein composi-
tion between type A protein (AA) which dissolves, and
amyloid (AL) of light chain, which is resistant and appears
in the sections. Laryngeal amyloidosis is a type of localized
amyloidosis that is characterized by monoclonal deposits
of the light chain type (AL) [10].
Magnetic resonance imaging (MRI) is the technique of
choice to detect the most specific features, since amyloid
deposits present an intermediate T1-weighted signal
intensity and low T2-weighted signal intensity, and MRI
is thus considered to be a more specific technique than CT
scanning [12]. Unfortunately, in our case, it was not
possible to conduct an MRI scan due to technical reasons
(the university hospital magnet was out of order). Thus,
regarding the diagnostic approach, a high disease suspi-
cion index followed by serum and urine electrophoresis,
rectal biopsy, punch biopsy during direct laryngoscopy
and MRI constitute an effective diagnostic procedure. Of
course, the pathologist—as mentioned above—contri-
butes significantly in the diagnosis of the disease.
Inourcase,theexcisedmasswasovalshaped,uncapsulated,
tumor-like yellow-gray nodule. Microscopically, the mass
was composed of micronodules consisting of amorphous,
acellular, eosinophilic, glassy material with variable inflam-
matory reactions including lymphocytes (Figure 2). Foreign
body giant cells were also seen engulfing fragments of
Figure 2. Aggregates of acellular eosinophic material typical
of amyloid associated with sparse inflammatory cells
(H&E × 100).
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gence under polarized light was diagnostic of amyloid
(Figure 3).
There are indications that immunological mechanisms are
involved in the pathogenesis of human amyloidosis and
that the latter could be a complication in immunodefi-
cient conditions. Factors that affect the human immune
response, such as steroids, immunosuppressive and
ionizing radiation, may accelerate the appearance of the
disease. Some types of amyloid deposits may be the result
of an immunocyte dyscrasia or mucosa associated
lymphoid tissue neoplasms [13]. Although systemic
amyloidosis presents a poor prognosis due to accumula-
tion of amyloid protein in a variety of vital organs
impairing their structure and function, localized primary
amyloidosis carries a much better prognosis. Therefore, it
is crucial to identify the local presence of the amyloid
protein by the above-mentioned procedures, since in
contrast to systemic amyloidosis, local amyloidosis pre-
sents a very good prognosis. The treatment of primary
localized laryngeal amyloidosis is surgical and may be
performed with the aid of laser technology. Endoscopic
CO2 laser excision of the mass should be the first line of
therapy. The course of the condition under discussion is
slow but sudden relapse is possible [14]. However, relapse
may occur after a long time period; long-term follow up is
essential for at least 5 to 7 years [1]. In this case, evolution
into the systemic form of the disease was not observed in a
20-month follow-up; there was no disease recurrence and
the patient was free of symptoms in this time period and
was in a good state of health. It is important to mention
that in contrast to local amyloidosis which carries a much
better prognosis, evolution into the systemic form of the
disease carries a poor prognosis because the accumulation
of amyloid fibrils in the tissues interferes with their normal
structure and function. In the study by Biewend et al. [1] in
a mean 7.6-year follow up of two patients no recurrence
was observed, while in another study by Piazza et al. [15],
17 out of 32 patients were asymptomatic in a 20-year
follow up. In secondary amyloidosis, a reduction in
amyloid deposition may occur following successful
treatment of the underlying disease.
Conclusions
Our case report is the second one in which dysphagia is
referred to as a disease symptom in primary localized
amyloidosis. The diagnosis of the disease is always
established histologically; surgical excision of the mass
by microlaryngoscopy using a CO2 laser technology
method was the therapy of choice.
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